About Innovation & Enterprise

To gear up A*STAR for an innovation-driven economy set out by Singapore’s Research Innovation Enterprise (RIE) 2025 masterplan, a new Innovation & Enterprise Group (“I&E”) which integrates the functions of the Industry Development Group and A*ccelerate Technologies is established. A*ccelerate Technologies will remain as an entity to commercialise A*STAR’s IP portfolio.

I&E will further strengthen A*STAR in generating economic and societal impact for Singapore. Importantly, I&E will create opportunities for greater synergies between A*STAR and partners in various types of collaborations, such as research collaborations, licensing, and spin-off efforts.

I&E will work across a range of industry clusters including Advanced Manufacturing & Precision Engineering,  Chemicals, Materials & Sustainability, Connectivity, Trade & Logistics, Consumer, Retail & Hospitality, Digital Services & Solutions, Electronics, Food & Nutrition, Human Potential, PharmBio & Bioprocessing, MedTech, Diagnostics & Digital Health.

I&E will also play a national role in terms of grant administration, and oversees 13 National Platforms like the Diagnostic Development Hub (DxD Hub) and Biomedical Sciences Industry Partnership Office (BMS IPO), among others.